When 13 GDMs were used as exposure, we found that succinimide increased the risk of AMD (OR = 1.33, p = 0.008), while DHEAS was a protective factor for AMD (OR = 0.87, p = 0.036). Here, SULT2A1 is linked to age-related macular degeneration.